Wedbush Securities’s Exact Sciences EXAS Stock Holding History

Wedbush Securities’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,719	Closed	-$254K	–	1094
2023 Q3	$254K	Sell	3,719 -1,026	-22%	-$87.1K	0.01%	797
2023 Q2	$446K	Sell	4,745 -612	-11%	-$47.7K	0.02%	584
2023 Q1	$363K	Buy	+5,357	New	+$344K	0.02%	668
2022 Q2	–	Sell	-5,427	Closed	-$379K	–	1103
2022 Q1	$379K	Sell	5,427 -1,094	-17%	-$80K	0.02%	698
2021 Q4	$508K	Buy	6,521 +1,583	+32%	+$140K	0.02%	626
2021 Q3	$471K	Buy	4,938 +685	+16%	+$72.3K	0.02%	641
2021 Q2	$529K	Buy	4,253 +1,860	+78%	+$222K	0.03%	599
2021 Q1	$315K	Buy	+2,393	New	+$328K	0.02%	795
2020 Q4	–	Sell	-1,985	Closed	-$202K	–	905
2020 Q3	$202K	Buy	+1,985	New	+$171K	0.02%	766

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wedbush Securities's EXAS Position: Q4 2023 in Review

Wedbush Securities sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 3,719 shares — an estimated $254K sold.

Wedbush Securities first reported a position in EXAS in Q3 2020 and held it in 9 quarters. The position peaked at $529K in Q2 2021. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

Wedbush Securities reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
Wedbush Securities sold 3,719 Exact Sciences shares in Q4 2023, an estimated $254K.
Wedbush Securities first reported a position in Exact Sciences in Q3 2020 and held it in 9 quarters.
Wedbush Securities's Exact Sciences position peaked at $529K in Q2 2021.
646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Wedbush Securities's 13F filing for Q4 2023, filed 12 Feb 2024.